Investing Profile
Stacie Weninger
Your Intro Paths to Stacie Weninger
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Stacie is a member of
Harvard University Network
598 CONNECTIONS
Harvard University Network
87 CONNECTIONS
Fidelity Investments Network
46 CONNECTIONS
F-Prime Network
18 CONNECTIONS
Find Stacie Weninger on
cbCurrent Investing Position
Investment Range
$100K - $10.0M
Sweet Spot
$5.0M
Investments On Record
7
Stacie Weninger is on these Sector & Stage Rankings
Stacie Weninger's Investments On Record (5)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Atalanta Therapeutics | Series BJan 2025$97M Series AJan 2021$110M | $210M |
Tenvie Therapeutics | Series AJan 2025$200M | $200M |
Engrail Therapeutics | Series BMar 2024$160M | $390M |
Neumora Therapeutics | Series AOct 2021$400M | $510M |
Denali Therapeutics | Series BAug 2016$130M Series AMay 2015$220M | $350M |
Stacie Weninger's Experience
Executive Director F-PrimePresent
Science Program Director Fidelity InvestmentsPresent
Executive Director F-Prime Biomedical Research InitiativePresent
Senior Scientist, Neuron Cell PressPresent
Senior Analyst and Project Manager, Task Force on Women in Science Harvard UniversityPresent
Stacie Weninger's Education
Harvard University Doctor of Philosophy (Ph.D.) Neuroscience
Investors who invest with Stacie Weninger
Scouts & Angels Affiliated With Stacie Weninger